“Unfortunately, the entire evidence base has been perverted,” said Joseph Ross, a professor at Yale Medical School who has studied the issue. Continue reading →
Amgen Inc
Cancer Research False Claims
100 Amgen scientists were astonished to find that they were able to replicate the results of only 6 of 53 widely cited landmark cancer research papers.
Continue reading →
NYT Promotes Alzheimer’s Expansion
New York Times reporter Gina Kolata, broadcasts medical hype on the front page of the paper much the way Judith Miller broadcast hype fed to her by Ahmed Chalabi and the Iraq war lobby.[1] Continue reading →
ACRE–A High Powered Harvard Stealth Pharma Front Group
ACRE’s mission is to persuade physicians that MORE rather than less industry involvement in Continuing Medical Education programs is good for patients–much as industry’s "Harry and Louise" ads were aimed at convincing the public that universal healthcare was BAD for them. Continue reading →
Merck Paid Elsevier to Publish Phony Peer-Review Journal
Merck is reported to have created a fake "peer-reviewed" journal to present favorable data that made its potentially fatal drugs–Fosamax and Vioxx–look good. Continue reading →
Why big pharma mergers magnify failures_Haseltine_Atlantic
"Radical restructuring, not merger mania, is the need of our time." Dr. William Haseltine Continue reading →
Lawsuit Charges Medscape CME With Off-Label Promotion Scheme
New revelations in an unsealed whistleblower-initiated lawsuit filed in Boston add yet another dimension to the scope and magnitude of corruption that has derailed American medicine–the focus is tainted Continuing Medical Education. Continue reading →
Non-profit Fronts for Drug Industry_Boston Globe
These paid lobbying efforts on behalf of industry are carried out under the pretext of advocacy in the public interest.
Continue reading →
Medical Prostitution: Doctors On the Take–Minnesota an example, NYT
Minnesota is the first of a handful of states to pass a law requiring drug manufacturers to disclose payments to doctors.
Continue reading →
Cong. Hearings Loom: Pfizer, Halliburton
“No general counsel or CEO wants to have to explain to his board why the company's name is appearing on the front page of a news article in a scandal…"
Showdown Looms in Congress Over Drug Advertising on TV
The FDA is salivating in expectation of increased funding from the drug industry–ostensibly to speed up the reviewing process for TV ads.
NEJM- Caught Covering Up for National Kidney Foundation–an indudstry front group
Readers of the New England Journal of Medicine should be forewarned: The information in the pages of the NEJM is tainted by industry influence, its professional and scientific integrity are tainted. Continue reading →